Dashboard
Manage Tickers

PMVPPMV Pharmaceuticals, Inc.

Nasdaq pmvpharma.com


$ 1.74 $ 0.04 (2.34 %)    

Friday, 26-Apr-2024 15:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.02 $ -0.13 (-0.03 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.75
$ 1.69
$ 1.74 x 800
$ 1.75 x 1,000
$ 1.69 - $ 1.76
$ 1.18 - $ 9.72
336,037
na
84.03M
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-03-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jefferies-initiates-coverage-on-pmv-pharma-with-buy-rating-announces-price-target-of-5
Jefferies Initiates Coverage On PMV Pharma...
04/12/2024 13:22:03

Jefferies analyst Kambiz Yazdi initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target o...

pmv-pharmaceuticals-doses-first-patient-in-global-tumor-agnostic-phase-2-pynnacle-trial-for-rezatapopt-in-tp53-y220c-positive-solid-tumors
PMV Pharmaceuticals Doses First Patient In...
03/27/2024 12:10:37

pmv-pharmaceuticals-pynnacle-phase-i-data-of-rezatapopt-in-advanced-ovarian-cancer-featured-in-oral-presentation-at-2024-sgo-annual-meeting-on-womens-cancer
PMV Pharmaceuticals PYNNACLE Phase I Data ...
03/18/2024 20:02:36

Phase 1 analysis from the PYNNACLE Phase 1/2 study showed promising efficacy of rezatapopt (PC14586) in heavily pre-treated pat...

hc-wainwright--co-reiterates-buy-on-pmv-pharma-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on PMV ...
03/07/2024 12:11:00

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

pmv-pharmaceuticals-fy23-eps-144-vs-161-yoy
PMV Pharmaceuticals FY23 EPS $(1.44) Vs $(...
02/29/2024 21:19:27

Fiscal Year 2023 Financial ResultsAs of December 31, 2023, PMV Pharma had $228.6 million in cash, cash equivalents, and marketa...

pmv-pharmaceuticals-plans-workforce-reduction-of-approximately-30-reveals-prioritization-of-pc14586-development-and-focused-discovery-research-efforts-results
PMV Pharmaceuticals Plans Workforce Reduct...
01/18/2024 21:03:18

Unaudited cash, cash equivalents, and marketable securities totaling approximately $229 million as of December 31, 2023, combin...

pmv-pharmaceuticals-promoted-michael-carulli-to-cfo-succeeding-winston-kung-who-is-stepping-down-to-pursue-other-opportunities
PMV Pharmaceuticals Promoted Michael Carul...
01/05/2024 21:03:32

ladenburg-thalmann-initiates-coverage-on-pmv-pharma-with-buy-rating-announces-price-target-of-7
Ladenburg Thalmann Initiates Coverage On P...
12/27/2023 12:02:59

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Pri...

recap-pmv-pharma-q3-earnings
Recap: PMV Pharma Q3 Earnings
11/09/2023 13:50:12

pmv-pharma-q3-eps-034-beats-045-estimate
PMV Pharma Q3 EPS $(0.34) Beats $(0.45) Es...
11/09/2023 13:12:30

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.45) by...

hc-wainwright--co-maintains-buy-on-pmv-pharma-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on PMV P...
10/16/2023 10:25:59

HC Wainwright & Co. analyst Robert Burns maintains PMV Pharma (NASDAQ:PMVP) with a Buy and lowers the price target from ...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
10/13/2023 17:31:10

why-belden-shares-are-trading-lower-by-over-25-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Belden Shares Are Trading Lower By Ove...
10/13/2023 17:14:35

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing o...

precision-oncology-pmv-pharmaceuticals-reveals-early-data-from-cancer-study-in-pretreated-patients
Precision Oncology PMV Pharmaceuticals Rev...
10/12/2023 18:13:58

PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
10/12/2023 17:37:47

pmv-pharmaceuticals-shares-resume-trade
PMV Pharmaceuticals Shares Resume Trade
10/12/2023 16:39:43

pmv-pharmaceuticals-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--154
PMV Pharmaceuticals Shares Halted On Circu...
10/12/2023 16:35:35

pmv-pharmaceuticals-updated-pc14586-phase-1-data-demonstrated-anti-tumor-activity-across-multiple-solid-tumor-types-with-a-tp53-y220c-mutation
PMV Pharmaceuticals Updated PC14586 Phase ...
10/12/2023 16:32:24

Updated PC14586 Phase 1 data presented today as a late-breaking poster at 2023 AACR-NCI-EORTC International Conference on Molec...

pmv-pharmaceuticals-to-present-updated-phase-1-data-on-pc14586-at-the-2023-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-and-host-a-kol-webinar
PMV Pharmaceuticals To Present Updated Pha...
10/11/2023 16:05:17

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecul...

why-flux-power-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Flux Power Shares Are Trading Lower By...
09/22/2023 18:22:36

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION